Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling

Poloxamer-188 (P188) is a nonionic triblock linear copolymer that can be used as a pharmaceutical excipient because of its amphiphilic nature. This study investigated whether P188 can act as an adjuvant to improve the immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chao-Hung, Lin, Yu-Jen, Cheng, Li-Ting, Lin, Chien-Hung, Ke, Guan-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145454/
https://www.ncbi.nlm.nih.gov/pubmed/35632471
http://dx.doi.org/10.3390/vaccines10050715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145454/
https://www.ncbi.nlm.nih.gov/pubmed/35632471
http://dx.doi.org/10.3390/vaccines10050715

Ejemplares similares